Human gene
IMPG2 interphotoreceptor matrix proteoglycan 2
1 disease group in OMIA reaches this gene, through the animal gene that Ensembl gives as its ortholog. The page shows the chain. It does not say whether an animal is a model of a human disease.
Animal diseases
By each group's best natural-model score, highest first. How the score works.
| OMIA group | Name | Species | Animal gene | Ortholog | The chain reached | Best score |
|---|---|---|---|---|---|---|
| 2289 | Retinal atrophy, progressive, IMPG2-related | dog | IMPG2 | one to one | Target evidence |
52.9
|
Target evidence
Each Open Targets association between this gene and a human disease that a disease group reached.
| Human disease | Mondo | Score | Evidence |
|---|---|---|---|
| retinitis pigmentosa 56 | MONDO:0013314 | 0.68 | 49 |
| vitelliform macular dystrophy 5 | MONDO:0014509 | 0.65 | 32 |
Drugs
Each ChEMBL drug that acts on this gene.
No ChEMBL drug acts on this gene, among the genes with target evidence.